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Abstract: Puumala virus (PUUV) is the agent of nephropathia epidemica (NE), a mild form of
hemorrhagic fever with renal syndrome (HFRS) in Europe. NE incidence presents a high spatial
variation throughout France, while the geographical distribution of the wild reservoir of PUUV, the
bank vole, is rather continuous. A missing piece of the puzzle is the current distribution and the
genetic variation of PUUV in France, which has been overlooked until now and remains poorly
understood. During a population survey, from 2008 to 2011, bank voles were trapped in eight
different forests of France located in areas known to be endemic for NE or in area from where no NE
case has been reported until now. Bank voles were tested for immunoglobulin (Ig)G ELISA serology
and two seropositive animals for each of three different areas (Ardennes, Jura and Orleans) were
then subjected to laboratory analyses in order to sequence the whole S, M and L segments of PUUV.
Phylogenetic analyses revealed that French PUUV isolates globally belong to the central European
(CE) lineage although isolates from Ardennes are clearly distinct from those in Jura and Orleans,
suggesting a different evolutionary history and origin of PUUV introduction in France. Sequence
analyses revealed specific amino acid signatures along the N protein, including in PUUV from the
Orleans region from where NE in humans has never been reported. The relevance of these mutations
in term of pathophysiology is discussed.
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1. Introduction
Hantaviruses are emerging zoonotic pathogens distributed worldwide except in Antarctica [1].
They may cause two severe pathologies in humans: hemorrhagic fever with renal syndrome
(HFRS) and hantavirus cardiopulmonary syndrome (HCPS) [2]. Viruses of the genus Hantavirus
are exceptions within the Bunyaviridae family, in being directly transmitted via aerosols ofsmall
mammals (rodents, shrews, moles, and bats) excreta with no role for arthropod vectors (insects
and ticks). Although a growing diversity of hantaviruses has been discovered over the last decade
in insectivores and bats [3], up to now, only rodent-borne hantaviruses have been shown at the
origin of human diseases. Hantaviruses are small, enveloped viruses, possessing a tri-segmented
RNA genome of negative polarity: S (small) segment codes for the nucleocapsid protein and
a small non-structural (NS)s protein [4] in several viral species; M (medium) segment for the
glycoprotein precursor (GPC) of the envelope glycoproteins Gn and Gc; and L (large) segment for the
RNA-dependent RNA polymerase (RdRp) [5]. Each hantavirus is predominantly associated with one
or a few distinct mammal species and this stable virus–host association underscore the importance
of host-related factors for understanding current distribution, evolution and epidemiology and
mechanisms of emergence.
In Europe, zoonoses associated with hantaviruses have been recognized as a growing public
health concern because of the increase of epidemics in frequency, amplitude, and geographic
expansion [6]. Among hantavirus species, Puumala virus (PUUV) is the agent of nephropathia
epidemica (NE), a mild form of HFRS in Europe. The geographical distribution of the rodent reservoir
of PUUV, the bank vole (Myodes glareolus), is rather continuous throughout a large part of Europe.
However, the spatial distribution of NE incidence is substantially smaller with a high variation at
large as well as at small geographical scales [7]. The reason for this discrepancy in distribution
between the reservoir and the disease is not clearly elucidated [7]. Among likely explanations, it could
be that many NE cases remain undetected or misdiagnosed due to mild symptoms which possibly
lead to confusion with other diseases and to a lack of clinician awareness for hantavirus diseases in
non-endemic areas. Alternatively, bank voles could be free of PUUV infections in specific areas or
PUUV strains that circulate in these areas would be not transmitted to or infectious for humans or
provoke a milder infection.
France offers an excellent situation to study this discrepancy since it hosts the western limit of the
NE endemic region in Europe, the disease being reported only in the northeastern part, although the
bank voles live almost all over the country. It is therefore important to evaluate at the country level
the current distribution and the genetic characteristics of the PUUV strains circulating in bank voles.
To date, eight PUUV lineages have been described in Europe which show a strong geographical
clustering [8,9] the Central European (CE) lineage (including strains from Belgium, Germany, and
Slovakia) [10,11], the Alpe-Adrian (ALAD) lineage [12], the Latvian (LAT) lineage [13], the Danish
(DAN) lineage [9,14], the south-Scandinavian (S-SCA) lineage [15], the north-Scandinavian (N-SCA)
lineage [15,16], the Finnish (FIN) lineage [9,14] and the Russian (RUS) lineage [9]. Data are missing
at the French level, only S and partial M segment sequences of viruses circulating in bank voles from
the Jura region have been published, they clustered with the CE lineage. In the present study, we
have performed phylogenetic analyses to specify the place of French isolates within the European
PUUV phylogeny and we have looked for PUUV genetic differences between NE endemic and
non-endemic areas.
Eight large forests constituted mainly by the same species of trees (beech, oak and pines)
were selected. They are in areas located either in or bordering or out of the endemic zone for
NE in human. Rodent trapping was performed between 2008 and 2011 to determine the global
seroprevalence of PUUV in bank vole populations. We then focused on the three forests presenting
the higher seroprevalence and number of positive rodents to determine the genetic characteristics of
the circulating viruses: two areas where NE cases are regularly reported, i.e., the French Ardennes and
the Jura in the north and east of France, respectively; a third area where NE cases have never been
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reported, the Orleans region in the Centre of France. Two PUUV representative isolates from each
of the three forests were sequenced over their full length coding regions including the L segment
(6530–6562 nucleotides (nt); 2156 amino acids (aa)), the M segment (3682 nt; 1148 aa) and the S
segment (1826–1830 nt; 433 aa).
Altogether, this study provides an up-to-date map of PUUV diversity in bank voles in France
and improves our understanding of PUUV epidemiology and of NE incidence in different regions
of France.
2. Materials and Methods
2.1. Rodent Trapping and Dissection
The trapping protocol consisted in lines of 34 and quadrats of 5 ˆ 5 Ugglan traps separated
from each other by a distance of 15 meters that were deployed for 3 successive nights. Captured
rodents were weighted, sexed and blood-sampled. Blood was taken from the retro-orbital sinus and
the rodent was either released or euthanized following the guidelines from Sikes et al. [17] for liver
and lung sampling. Lungs and liver were stored in dry tubes and immediately frozen.
All the procedures were carried out according to EC Directive 86/609/EEC for
animal experiments.
2.2. Serological and Molecular Analysis
Serum samples were screened for previous PUUV exposure by an immunoblogulin (Ig)G
ELISA on plaques coated with N recombinant protein of PUUV or controls as already described in
Billecocq et al. [18].
Two representative isolates from each sampling areas, named PUUV/Ardennes/Mg75/2011
and PUUV/Ardennes/Mg156/2011 for Ardennes (collection date: November 2011),
PUUV/Jura/Mg2/2010 and PUUV/Jura/Mg214/2010 for Jura (collection date: July 2010), and
PUUV/Orleans/Mg23/2010 and PUUV/Orleans/Mg29/2010 for Orleans (collection date: June
2010) were used for the complete S, M and L sequences recovery.
RNA was extracted from lung tissue samples of positive bank voles using the TriSURE reagent
(Bioline, London, UK) following the manufacturer’s recommendations. Reverse transcription-PCR
(RT-PCR) was performed essentially as described earlier in Plyusnina et al. [19]. Sequences of primers
are available upon request. PCR-amplicons were purified from agarose gel and sequenced by the
Sanger method.
Complete S, M and L sequences of the six samples were deposited in GenBank database under
accession numbers KT247592–KT247609 (Supplementary Table S1).
Datasets included in the study are constituted as follow.
S dataset: We used a dataset composed of the complete coding S segment sequences
(nucleoprotein) of the six newly sequenced French isolates from Ardennes, Jura and Orleans and
of 181 PUUV and Asian PUUV-like sequences. The five PUUV sequences (KC676609, KC676611,
KC676613, KC676614, and KC676615) from Croatia, the five PUUV sequences (AB433846, AB433847,
AB433848, AB433842, and AB433844) from Russia and the three PUUV sequences (EU439969,
EU439971, and EU439972) from Germany, for which the regions encoding the first 3, 14 and 18
amino acid residues, respectively, are lacking, were added to the PUUV group in order to improve
the representativeness of these geographic areas. The Asian PUUV-like sequences correspond to the
Asian provisional species Hokkaido virus (HOKV), Muju virus (MUJV) and Fusong virus (FUSV) as
reported in the 9th ICTV Report [20], in order to include all known viruses with complete coding
sequences for the S segments (S, open reading frame (ORF), 1293 bp).
M dataset: We used a dataset composed by the partial (2484–3010 nt) M segment sequences of
the six newly sequenced French isolates and of 49 PUUV and Asian PUUV-like sequences.
5478
Viruses 2015, 7, 5476–5488
L dataset: We used a dataset composed by the partial (577–989 nt) L segment sequences of the
six newly sequenced French isolates and of 53 PUUV and Asian PUUV-like sequences.
All sequences were obtained from the National Institute of Allergy and Infectious Diseases
(NIAID) Virus Pathogen Database and Analysis Resource (ViPR) [21,22] online through the
website http://www.viprbrc.org. The list of viruses and their geographic origin are displayed in
Supplementary Table S1.
Multiple sequence alignments were prepared with the Clustal Omega alignment program
implemented in SEAVIEW v4.4.2 [23]. Nucleotide sequences were translated into amino acid
sequences and analyzed with SEAVIEW v4.4.2. Phylogenetic reconstructions were conducted
using the Maximum Likelihood (ML) approach implemented in PhyML v3.0 [24] with a statistical
approximate likelihood ratio test (aLRT) of branch support, using the Asian PUUV-like species
as outgroup. The optimal substitution model was identified as the GTR+G+I model (General
Time Reversible) for the three segments, using a function implemented in Mega v6.0 [25]. The
transition/transversion ratio was fixed to 4 and nucleotide frequencies were optimized from the data
set. Rate heterogeneity was applied using discrete gamma distribution with four rate categories, and
the shape parameter alpha was estimated from the data set.
Estimate of evolutionary divergence (nucleotide and amino acid genetic diversity) within and
between lineages was calculated using a function implemented in the Mega v6.0 program. Analyses
were conducted using the Maximum Composite Likelihood (nucleotide) or the Poisson (amino acid)
substitution model. The rate variation among sites was modeled with a gamma distribution (shape
parameter = 1). All the other parameters were set to their default.
3. Results
3.1. Seroprevalence
From 2008 to 2011, 1302 bank voles have been captured in the eight targeted French forests,
of which 184 reacted positively by IgG ELISA against the recombinant PUUV N protein. The
mean seroprevalence of 14.1% was, however, not homogeneously distributed (Table 1). Globally,
the positive rodents were mostly found in the northeastern of France, the region endemic for NE
in human, with 16% to 29.7% in Ardennes and Jura, respectively. In addition, no positive rodent
was found in the southern regions that are not endemic for NE. However, 25 positive bank voles
were detected among populations sampled in an area free of NE, neighboring the endemic area:
the Orleans region. This region harbored a particularly high seroprevalence in bank voles (17.2%)
comparable to that observed at the same period in the endemic area. About 200 of the rodent
sera were systematically submitted both to serological test and to nested RT-PCR according to
Bowen et al. [26]. As PCR positive sera were only found in a subset of the seropositive animals (data
not shown), we then decided to test only the seropositive rodent sera by RT-PCR.
Table 1. Results of bank voles captures and seroprevalence.
Geographic
Area: City
(Department)
Date NEStatus
N˝ of Tested
Bank Voles
N˝ of PUUV
Seropositives
Seroprevalence
(%)
N˝ of
RT-PCR +
N˝ of
Nested +
Charleville
(Ardennes)
October 2008
Endemic 511 82 16.0 6 (1%) 42 (8%)
May–June 2009
June 2010
November 2011
Troyes (Aube)
May 2008
Endemic 34 5 14.7 0 1 (3%)October 2008
September 2009
Dole (Jura) Jun 2010 Endemic 229 68 29.7 9 (3.9%) 33 (14%)
Senart (Essonne)
May 2008
Endemic 106 4 3.8 0 1 (0.9%)October 2008
September 2009
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Table 1. Cont.
Geographic
Area: City
(Department)
Date NEStatus
N˝ of Tested
Bank Voles
N˝ of PUUV
Seropositives
Seroprevalence
(%)
N˝ of
RT-PCR +
N˝ of
Nested +
Orléans (Loiret)
June 2008
Free 145 25 17.2 1 (0.7%) 17 (12%)
October 2008
April 2009
June–July 2010
Fontenay-le
Comte (Vendée) Jun 2009 Free 19 0 0
Meillers (Allier)
Jun 2008
Free 227 0 0
Sept 2008
Apr 2009
May 2009
Bourg en Bresse
(Ain)
Mar 2008
Free 31 0 0May 2008
Sept 2009
TOTAL 1302 184 14.1 16 (1.2%) 94 (7.2%)
NE: Nephropathia Epidemica; PUUV: Puumala virus; RT-PCR: reverse transcription-PCR.
3.2. Phylogenetic Analyses
In order to elucidate if genetic differences in the PUUV viruses circulating in the different regions
may explain the discrepancy in human transmission, we have compared viral isolates representative
of the Orleans non-endemic region to those selected in the two main endemic areas of Charleville and
Dole. This corresponds to the first description of the complete genome coding sequences of PUUV
strains circulating in bank vole populations in France. Until now, only S and partial M segment
sequences from PUUV circulating in the Jura region have been published [27]. Complete coding
sequences of the three genomic segments of two PUUV isolates for each of the three areas presenting
the higher seroprevalence and number of positive rodents were determined (See Supplementary
Table S1 for their GenBank accession numbers).
Phylogenetic analysis of the complete S coding sequences showed, as expected, that the French
PUUV isolates cluster among the CE lineage (Figure 1) (bootstrap support value of 99%).
This is highlighted in Figure 2 that focused on the CE lineage that also included the Belgian,
German and Slovakian isolates. Interestingly, isolates from Ardennes are more closely related to
the Belgian isolates, which appear to be logical considering their geographic proximity. However,
isolates from Jura/Orleans occupied an outsider’s position without being in close proximity to each
other: while the two Orleans isolates are very similar, those from Jura are distinct, one segregating
closer to the isolate from MignovillardY02 previously published [27], the other being more related to
the Orleans isolates.
Phylogenetic analyses of the partial M and L segment sequences confirm this result (Figure 3).
Although all the lineages are not represented because of a lack of sequences, French isolates clustered
in both phylogenies among the CE lineage, with a clear division between isolates from Ardennes and
isolates from Orleans and Jura. Similarly to the S segment, the M segment analysis shows that isolates
from French Ardennes are very close to strains from Belgian Ardennes.
3.3. Genetic Diversity of French Isolates
Analyses of the complete coding sequence estimate that the evolutionary divergence between the
PUUV lineages in France reaches up to 18% at the nucleotide level and 3% at the amino acid level for
the S segment (Figure 2 and Table 2). This divergence is almost the same for the other segments with
a global tendency to slightly more divergence for the M segments (19% nt and 4% aa) and slightly less
divergence for the L segment (15% nt and 3% aa). As already documented for PUUV [28,29] or other
hantaviruses [30], only a few non-synonymous substitutions are observed, the majority of mutations
are silent, suggesting strong purifying selection.
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Figure 1. Circular phylo-tree based on the complete N protein coding sequences (the S segment  
N-open reading frame (ORF)). The same colors are used for the known Puumala virus (PUUV) 
lineages and their respective countries of origin on the map. French PUUV from this study are 
highlighted in red on the tree and red points on the map indicate their geographic localizations.
Figure 1. Circular phylo-tree based on the complete N protein coding seq ences (the S segment
N-op n reading fram (ORF)). The same c lors are used for th known Puumala virus (PUUV)
lineages and their respective cou tries of origin on the map. French PUUV from this study are
highlighted in red on the tree and red points on the map indicate their geographic localizations.
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Figure 2. Phylogenetic tree based on the complete N protein coding sequences (the S segment N- ORF) of PUUV of the central European (CE) lineage. Scale bar represent 
the average number of substitutions per site. French isolates from this study are in red and specific amino acid (aa) signatures are indicated on the branches of the tree. 
Figure 2. Phylogenetic tree based on the complete N protein coding sequences (the S segment N- ORF) of PUUV of the central European (CE) lineage. Scale bar
represent the average number of substitutions per site. French isolates from this study are in red and specific amino acid (aa) signatures are indicated on the branches
of the tree.
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Figure 3. Phylogenetic trees based (A) on the partial (2484–3010 nt) M segment sequences and (B) on the partial (577–989 nt) L segment sequences of PUUV. Scale bar 
represent the average number of substitutions per site. French isolates are in red. Blue bars indicate known PUUV lineages. 
 
Figure 3. Phylogenetic trees based (A) on the partial (2484–3010 nt) M segment sequences and (B) on the partial (577–989 nt) L segment sequences of PUUV. Scale
bar represent the average number of substitutions per site. French isolates are in red. Blue bars indicate known PUUV lineages.
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Table 2. Evolutionary divergence between French PUUV isolates nucleotide sequence (A) and amino
acid sequence (B) levels. The results are expressed in percentage (%) of divergence. *: not tested.
(A)
Nucleotide
S segment M segment L segment
1 2 3 4 5 6 1 2 3 4 5 6 1 2 3 4 5 6
(1) Ard156 * * *
(2) Ard75 0 * 1 * 2 *
(3) OR23 17 17 * 19 18 * 14 15 *
(4) OR29 18 17 0 * 18 17 2 * 14 15 1 *
(5) JU2 16 15 7 7 * 14 14 17 16 * 12 12 10 10 *
(6) JU214 16 15 15 15 7 * 14 14 17 15 1 * 12 11 9 9 3 *
(B)
Amino acid
S segment M segment L segment
1 2 3 4 5 6 1 2 3 4 5 6 1 2 3 4 5 6
(1) Ard156 * * *
(2) Ard75 0 * 0 * 1 *
(3) OR23 3 3 * 3 3 * 3 3 *
(4) OR29 3 3 0 * 3 3 1 * 2 3 0 *
(5) JU2 2 2 2 2 * 2 2 4 3 * 2 2 2 2 *
(6) JU214 1 1 2 2 1 2 3 4 3 0 * 2 3 2 2 1 *
3.4. Amino Acid Specific Signatures
All genetic lineages of PUUV possess specific amino acid “signatures” [9]. Concerning the
French isolates, it is of note that within the CE lineage, only those from Ardennes possess the Q64
signature characteristic of the Belgian strains [9], outlining the close relationship between them. This
residue is embedded in the major antigenic site of the N protein. On the other hand, sequences from
Orleans have two specific amino acid residues (V10 within the major antigenic site and A294) at
very conserved positions and share another one with the JU2 Jura isolate, K258 located in the hyper
variable region of the protein (Figure 4).
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Figure 4. PUUV nucleocapsid protein aa sequence visualized with Protter—visualize proteoforms 
[31]. The used aa sequence corresponds to the consensus sequence of the S sequences dataset. The 
major antigenic domain (MAD) is represented in green and the hyper variable region (HVR) in blue. 
Figure 4. PUUV nucleocapsid protein aa sequence visualized with Protter—visualize
proteoforms [31]. The used aa sequence corresponds to the consensus sequence of the S sequences
dataset. The major antigenic domain (MAD) is represented in green and the hyper variable region
(HVR) in blue.
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4. Discussion
The distribution and genetic variability of PUUV circulating in France has been overlooked until
now and remains poorly understood. During a population survey from 2008 to 2011, we trapped 1302
bank voles in eight different forests of France located in four regions known to be endemic for NE
and four regions from where no NE case has been reported until now. Surprisingly, rodents from one
forest located outside the endemic area, in the Orleans region, harbored a high PUUV seroprevalence
(17.2%) comparable to that observed in the endemic area. To explore if genetic characteristics of the
corresponding viruses may explain this discrepancy in human transmission, we have compared the
complete genome coding sequences of two PUUV isolates for the non-endemic Orleans region with
two PUUV isolates for each of two areas where NE cases are most regularly reported, the French
Ardennes and the Jura. This study constitutes the first molecular description of the complete genome
of French PUUV isolates and the first description of the French PUUV isolates diversity between
endemic and non-endemic areas.
Phylogenetic analyses using N, M and L coding regions revealed that French PUUV isolates
belong logically to the CE lineage. However, strains from Ardennes are significantly divergent
from those from Jura and Orleans. Our results suggest two separate introductions of PUUV (from
a hypothetical “German ancestor”) to what is currently the territory of France: first, from what is
currently Belgium, establishing the Ardennes sublineage, very closely related to the Belgium strains
circulating just across the French–Belgian border [11]. The members of this sublineage are sharing
their specific Q64 amino acid signature embedded in the major antigenic domain of the N protein [9].
The other sublineage is more spread across a central area in France, from east (Jura) to central
(Orleans). It is more divergent and may originate directly from what is currently Germany or from
central European areas. It also presents specific amino acid signatures more dispersed along the N
protein, from the major antigenic domain at the N-terminus to the central hyper-variable region. An
interesting point concerns the two isolates from the Dole forest (JU2, JU214) that behave differently in
phylogenies realized with the different gene segments. Using M segment they are closely related and
distinct from the Orleans isolates (OR23, OR29). Using S segment, JU2 is closer from the OR isolates,
while using L segment, JU214 is closer from them. How this observation would suggest a possible
reassortment between segments remains unclear and must be verified by increasing the number of
sequences to be compared.
A microevolution process with accumulation of point mutations at a local geographic scale
resulting in the generation of few preferred genotypes [28,29], could constitute a second hypothesis
to explain this co-circulation of PUUV strains in France.
Sequence analyses revealed specific amino acid signature of the Orleans region, from where NE
in humans has never been reported. Three of these residues are located within the major antigenic
domain [32–34] or within the hyper variable region [9] both carrying antigenic epitopes. It would
be interesting to investigate if the point mutation V10D in the main antigenic of N, specific to the
Orleans isolates, results in modification in antigenicity. This may induce a stronger immunogenicity
in humans leading to a better virus clearance explaining that no human case is observed in the
Orleans area. The inverse hypothesis may be formulated, based on the observation that for many
viruses, pathogenicity is linked to a disproportioned innate immune response able to induce damages
to the host [35] what may be the reason of an immune mediated pathogenesis in hantavirus
infection [36]. In this case, the V10D mutation could be responsible for a lower activation of the innate
immune system and thus reduced pathogenic infection in humans. It would be important to clarify
whether these subtle differences between genetically closely related hantaviruses may induce very
different virulence. Currently, no reverse genetic system is available for hantaviruses to investigate
this point and only comparative genomics may help to understand the determinants of excretion,
transmission and human pathogenicity [37]. Alternatively to these hypotheses about strain virulence
or immunogenicity, different human exposure due to rodent dynamics or human behavior may also
contribute to the efficiency or the opportunity of virus transmission [38,39].
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The recent discovery of NE cases far outside the reported area for NE distribution in France [40]
emphasizes the need for a better assessment of PUUV distribution and diversity in a country that
limit the endemic area at the western part of Europe. Moreover, further phylogeographic analyses
are needed to investigate the dynamics and evolutionary history of viral populations of PUUV at the
European level and notably to reconstruct the precise origins of the French lineages. At the present
stage, insufficient geographical sampling could influence phylogeographic interpretations [41,42].
Many areas/countries are still suffering a lack of sufficient data, only based on very short sequences,
and there is a crucial need to develop an adequate sampling coverage for studying the genetic
variation of PUUV in France and in Europe. This would allow better statistical evaluations of future
phylogeographical hypotheses [42].
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